Related case: ISADAP 2017 ISADDP Appeal Decision 20164962 - Appeal May 31, 2017 In May 2016 Sport Ireland (Spórt Éireann) has reported an anti-doping rule violation against the Athlete IS-4962 after his A and B samples tested positive for the prohibited substance Methylhexaneamine (dimethylpentylamine). After notification a provisional suspension was ordered. The Athlete filed a statement in his defence, he did not accept the sanction proposed by Sport Ireland and was heard for the GAA Anti-Doping Hearing Committee. The Athlete admitted the violation and denied the intentional use of the substance. He stated that had used a number of supplements provided by the regular nutritionist. Because he didn’t like the caffeine gel he purchased caffeine tablets Falcon Labs Oxy Burn Pro recommended by a casual friend. He asserted that he researched the ingredients of the product on the internet before using and mentioned these caffeine tablets on the Doping Control Form. In fact the Oxy Burn Pro contained the prohibited substance as source of the positive test and it was not mentioned on the label of the product. He didn’t consult the nutritionist nor his general practitioner about the new product. The Athlete mentioned the lack of anti-doping information he received and the Hearing Committee finds that there was a confusing situation at the Kerry County Board about what players were told and the level of anti-doping instruction and education provided to the players. The Committee considers that the Athlete’s violation was not intentional, that he researched the product before using, admitted the violation and explained how the substance came into his system. The Athlete’s conduct showed also that he was educated enough to be aware of the existence of doping and the need to check his supplements. However he purchased the supplement following the recommendation of a casual friend and failed to consult the nutritionist or his own general practitioner about this product. Establishing No Significant Fault or Negligence for the Athlete’s conduct the GAA Anti-Doping Hearing Committee decides on 27 February 2017 to impose a 6 month period of ineligibility on the Athlete IS-4962. The sanction will start on the date of the provisional suspension, . 13 May 2016 and is without the 11 weeks he has already served.
Bill, PLEASE stop the ridiculous generalizations. You are only demonstrating how much you don’t know, and wasting people’s time. “No one’s eating ‘whole’ wheat”. Absolute demonstrable nonsense. Many people ARE eating whole wheat products. Many people make their own bread, even grind their own wheat, even make it with older forms of wheat, and other whole grains. I used to make my own bread with organic whole-grain flour. “Their (sic) not God”. Nor are you. There is no way you can possibly know what “everyone” or “no one” is doing. There are actually numerous studies that show that eating whole grains in moderation is beneficial. Whole grains (excepting modern standard hybrid wheat) are REAL Paleo, as science shows that humans have eaten grains, and, yes, ground it to flour, for more than 30,000 years. But Paleo man used grains like any other plant food resource – as a small, seasonal part of a varied diet. BTW, I will say it again. Anyone that wants a citation on a specific scientific claim I have made, please let me know. I will be happy to post one or more. But, with literally thousands of original source references I have looked at over the years, and continue to read, I cannot post them all. Nor am I intending to do an anthropology or physiology tutorial here. This is Chris Kresser’s blog, and not “Burke’s Introduction to Evolutionary Biology 101”. Commenters can check out the numerous references Chris provides, or they can Google specific topics in which they are interested. If their interest is genuine.
On April 8, 1997, after buying the remaining % of Roussel-Uclaf stock in early 1997,  Hoechst AG ( US$30 (equivalent to $ in 2016) billion annual revenue) announced the end of its manufacture and sale of Mifegyne ( US$ (equivalent to $ in 2016) million annual revenue) and the transfer of all rights for medical uses of mifepristone outside of the United States to Exelgyn ., a new single-product company immune to antiabortion boycotts, whose CEO was former Roussel-Uclaf CEO Édouard Sakiz.  In 1999, Exelgyn won approval of Mifegyne in 11 additional countries, and in 28 more countries over the following decade.